drug company funding for drug trials is leading to biased findings and inappropriate prescribing

July 2004

There's growing concern that drug company funding for drug trials is leading to biased findings and inappropriate prescribing.

In May we told you how physicians select one drug over another based on the way statistics are used and how study results are presented.

Now the AMA just launched a campaign to draw attention to "publication bias"...and get gov't help to curb these practices.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote